Jun 2026 (Q2 FY26) — Aug 11, 2026
BioHarvest Sciences Q2 FY26 — First CDMO Manufacturing Contract Secured, Strategic Shift to Monetization
Read the full callBioHarvest Sciences (BHST) earnings
- Jun 2026 (Q2 FY26)
- Dec 2025
BioHarvest Sciences earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Price
$1.7 −2.86% · −$0.05
Performance −85.9% 1Y
1Y: $12.03 on 14 Oct 2025 → $1.7. High $12.65 (15 Oct 2025), low $1.45 (24 Sept 2026).
- Previous close
- $1.75
- 52-week range
- $1.45 – $12.65
- One year
- −86.56%
Overview
- Symbol
- BHST
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
BioHarvest Sciences earnings calls (BHST)
Financials
What the filings say
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Reserves | -84 | -96 | -108 |
| Fixed assets | 4 | 8 | 8 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Cash from operations | -9 | -7 | -7 |
| Cash from investing | -1 | -3 | -2 |
| Cash from financing | 14 | 7 | 30 |
| Net cash flow | 4 | -3 | 21 |
| Capital expenditure | -1 | -3 | -2 |
| Free cash flow | -10 | -10 | -10 |
Insider filings
No filings in the last 12 months.
No officer, director or 10% owner of BHST filed a Form 4 in this window. That is a statement about filings, not about ownership — see the note below.
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for BIOHARVEST SCIENCES INC.
Free account. Everything above stays public.
Write why you follow BIOHARVEST SCIENCES INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading